← Back to Search

Therapy Dog Visits for Anxiety (CANINE III Trial)

N/A
Recruiting
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
4-17 years old;
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 minutes
Awards & highlights

CANINE III Trial Summary

This trial will measure the effects of a therapy dog visit on a child's anxiety in the ER, looking at patient perception and electrical resistance.

Who is the study for?
This trial is for children aged 4-17 who are experiencing moderate to high levels of anxiety, as determined by their primary care physician or nurse, while in the pediatric emergency department.Check my eligibility
What is being tested?
The study aims to see if spending time with a therapy dog and its handler can help reduce anxiety in kids at the ER. It compares kids' anxiety levels before and after meeting the dog using a special scale (FACES) and skin tests.See study design
What are the potential side effects?
There are no medical side effects expected from this trial since it involves interaction with a therapy dog rather than medication. However, potential risks may include allergic reactions or fear of dogs.

CANINE III Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 4 and 17 years old.

CANINE III Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in anxiety level of subject
Secondary outcome measures
Meds
Perception of anxiety level from parent(s)
Perception of anxiety level from physician
+3 more

CANINE III Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Dog + handlerActive Control1 Intervention
Group II: No dogPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
980 Previous Clinical Trials
983,196 Total Patients Enrolled
26 Trials studying Anxiety
9,584 Patients Enrolled for Anxiety

Media Library

Dog + handler Clinical Trial Eligibility Overview. Trial Name: NCT03784573 — N/A
Anxiety Research Study Groups: Dog + handler, No dog
Anxiety Clinical Trial 2023: Dog + handler Highlights & Side Effects. Trial Name: NCT03784573 — N/A
Dog + handler 2023 Treatment Timeline for Medical Study. Trial Name: NCT03784573 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment open to those aged seventy-five and above in this experimentation?

"This clinical trial is seeking participants of between 4 and 17 years old."

Answered by AI

What are the eligibility criteria for participating in this trial?

"The criteria for this clinical trial stipulates that candidates must be between 4 and 17 years old, as well as have a history of opioid use disorder. There are 80 available spots in total."

Answered by AI

How many individuals are participating in this experiment?

"Affirmative. According to clinicaltrials.gov, this ongoing medical experiment was first posted on July 1st 2019 and most recently edited on August 5th 2023. The research team is in search of 80 participants from a single location."

Answered by AI

Is this research endeavor available to participants currently?

"This clinical trial is still recruiting participants, as indicated by the recent update to its profile on clinicialtrials.gov that occured on May 8th 2023. The study was initially listed for prospective patients on January 7th 2019."

Answered by AI
~4 spots leftby Jul 2024